bpc-157 research safety is being marketed as a “healing peptide” for tendon injuries, joint pain, gut repair, inflammation, and recovery. The problem is that “healing” biology is not always simple in people with cancer The Hidden Risks of BPC‑157:

Injectable healing protocol: Dose: 2-3mg daily (higher end of range) Frequency: Daily throughout healing period Duration: Until wound resolves plus 1-2 weeks Injection site: Systemic (not into wound) Topical healing protocol: Concentration: 2-4% in wound-appropriate vehicle Application: 2-3 times daily to wound margins (not directly into open wounds) Duration: Throughout healing process Note: Consult healthcare provider for significant wounds GHK-CU pairs exceptionally well with BPC-157 and TB-500 for wound healing

Theres no official veterinary standard yet, but here are the ranges used most commonly in integrative practice

Without peer-reviewed human data, assertions of efficacy or safety stand primarily on animal studies, case reports, and anecdote

The peptide also demonstrated an ability to increase fat oxidation and energy expenditure through pathways independent of beta-3 receptors

Establishment of respiratory air-liquid interface cultures and their use in studying mucin production, secretion, and function

Can I take oral B12 instead of injections